kentucky semaglutide digestive blockage lawsuit As GLP-1 drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic feet." link in bio 🔗 Oral GLP-1 Receptor Agonist Weight

Studies indicate that non-diabetic men using semaglutide showed a higher likelihood of experiencing erectile dysfunction compared to control groups

July 2024

A second study compared the occurrence of FG in patients treated with SGLT2 inhibitors (15.0 per 100,000 person-years) vs DPP4 inhibitors (9.7 per 100 000 person-years) in men 65 years and older who have T2DM using large data bases (216)

Its a shame the Trump administration wont expand CMS coverage for these drugs, its not irrational

Between these two medication options, almost everyone who qualifies should be able to find an oral option that works for their health needs, Francavilla says

The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease